SignalMed+ Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

SignalMed+ General Information

Description

Developer of EEG monitoring and analysis software intended to support monitoring and prediction of brain states during anesthesia. The company's technology employs real-time electroencephalogram signal processing combined with computational neuroscience modeling and artificial intelligence to extract hidden patterns from high-dimensional brain data, enabling hospitals to optimize anesthesia control and provide early detection of recovery in comatose patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 229 rue Saint-Honore
  • 75001 Paris
  • France
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 229 rue Saint-Honore
  • 75001 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SignalMed+ Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
To view SignalMed+’s complete valuation and funding history, request access »

SignalMed+ Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Paris Biotech Sante Accelerator/Incubator
To view SignalMed+’s complete investors history, request access »

SignalMed+ FAQs

  • When was SignalMed+ founded?

    SignalMed+ was founded in 2021.

  • Where is SignalMed+ headquartered?

    SignalMed+ is headquartered in Paris, France.

  • What industry is SignalMed+ in?

    SignalMed+’s primary industry is Decision/Risk Analysis.

  • Is SignalMed+ a private or public company?

    SignalMed+ is a Private company.

  • What is SignalMed+’s current revenue?

    The current revenue for SignalMed+ is .

  • Who are SignalMed+’s investors?

    Paris Biotech Sante has invested in SignalMed+.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process